Bonk (NASDAQ:BNKK) Director Mitchell Austin Rudy Buys 9,000 Shares

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy acquired 9,000 shares of the company’s stock in a transaction dated Monday, July 13th. The stock was acquired at an average cost of $1.21 per share, with a total value of $10,890.00. Following the transaction, the director directly owned 95,000 shares of the company’s stock, valued at approximately $114,950. This represents a 10.47% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Mitchell Austin Rudy also recently made the following trade(s):

• On Friday, July 10th, Mitchell Austin Rudy acquired 1,000 shares of Bonk stock. The stock was bought at an average cost of $1.21 per share, for a total transaction of $1,210.00.
• On Thursday, July 2nd, Mitchell Austin Rudy bought 11,659 shares of Bonk stock. The stock was bought at an average cost of $1.47 per share, with a total value of $17,138.73.
• On Monday, June 22nd, Mitchell Austin Rudy bought 7,500 shares of Bonk stock. The stock was bought at an average cost of $1.56 per share, with a total value of $11,700.00.
• On Tuesday, June 16th, Mitchell Austin Rudy bought 2,500 shares of Bonk stock. The stock was bought at an average price of $1.32 per share, with a total value of $3,300.00.
• On Wednesday, June 10th, Mitchell Austin Rudy purchased 12,000 shares of Bonk stock. The shares were bought at an average cost of $1.37 per share, for a total transaction of $16,440.00.

Bonk Stock Up 11.0%

NASDAQ BNKK opened at $1.31 on Wednesday. The stock has a market cap of $10.48 million, a PE ratio of -0.28 and a beta of 1.89. Bonk, Inc. has a fifty-two week low of $1.14 and a fifty-two week high of $46.90. The business has a 50 day moving average price of $1.70 and a two-hundred day moving average price of $2.70.

Bonk (NASDAQ:BNKK) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The firm had revenue of $0.79 million for the quarter.

Analyst Upgrades and Downgrades

BNKK has been the subject of a number of analyst reports. Weiss Ratings cut shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. Wall Street Zen upgraded Bonk from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in BNKK. State Street Corp acquired a new position in Bonk during the 4th quarter worth $33,000. Steward Partners Investment Advisory LLC bought a new position in shares of Bonk during the fourth quarter worth about $37,000. Jane Street Group LLC bought a new position in shares of Bonk during the fourth quarter worth about $96,000. Finally, Geode Capital Management LLC acquired a new position in Bonk in the fourth quarter worth about $128,000. 12.55% of the stock is currently owned by institutional investors.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.